Home/Filings/4/0001144204-13-046285
4//SEC Filing

Tonix Pharmaceuticals Holding Corp. 4

Accession 0001144204-13-046285

$TNXPCIK 0001430306operating

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 3:34 PM ET

Size

7.1 KB

Accession

0001144204-13-046285

Insider Transaction Report

Form 4
Period: 2013-08-14
GERSHELL LELAND
CFO and Treasurer
Transactions
  • Purchase

    Common Stock, $0.001 par value

    2013-08-14+3,5308,830 total
  • Purchase

    Series A common stock purchase warrant

    2013-08-14+3,5303,530 total
    Exercise: $4.25From: 2013-08-14Exp: 2018-08-14common stock (3,530 underlying)
Footnotes (1)
  • [F1]Included in the purchase of 3,530 Units at a price of $4.25 per Unit. Each Unit consisted of one share of common stock and one Series A Warrant exercisable immediately for one share of common stock at an exercise price of $4.25 per share

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001430306

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 3:34 PM ET
Size
7.1 KB